State Street’s OptimizeRx OPRX Stock Holding History

State Street’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Sell	80,602 -397,178	-83%	-$2.28M	﹤0.01%	3614
2026 Q1	$3M	Buy	477,780 +249	+0.1%	+$2.31K	﹤0.01%	3167
2025 Q4	$5.85M	Buy	477,531 +84,808	+22%	+$1.39M	﹤0.01%	2924
2025 Q3	$8.05M	Buy	392,723 +3,691	+0.9%	+$58.6K	﹤0.01%	2753
2025 Q2	$5.25M	Buy	389,032 +29,513	+8%	+$323K	﹤0.01%	2921
2025 Q1	$3.11M	Buy	359,519 +2,656	+0.7%	+$16.2K	﹤0.01%	3068
2024 Q4	$1.73M	Buy	356,863 +6,770	+2%	+$37.8K	﹤0.01%	3361
2024 Q3	$2.7M	Buy	350,093 +1,811	+0.5%	+$16.1K	﹤0.01%	3218
2024 Q2	$3.48M	Buy	348,282 +13,443	+4%	+$148K	﹤0.01%	3082
2024 Q1	$4.07M	Buy	334,839 +14,280	+4%	+$207K	﹤0.01%	3009
2023 Q4	$4.59M	Sell	320,559 -165,259	-34%	-$1.59M	﹤0.01%	2986
2023 Q3	$3.78M	Sell	485,818 -6,253	-1%	-$68K	﹤0.01%	3062
2023 Q2	$7.03M	Buy	492,071 +69,169	+16%	+$985K	﹤0.01%	2826
2023 Q1	$6.19M	Sell	422,902 -277,997	-40%	-$4.65M	﹤0.01%	2909
2022 Q4	$11.8M	Buy	700,899 +21,201	+3%	+$367K	﹤0.01%	2599
2022 Q3	$10.1M	Buy	679,698 +19,815	+3%	+$392K	﹤0.01%	2709
2022 Q2	$18.1M	Buy	659,883 +54,484	+9%	+$1.61M	﹤0.01%	2327
2022 Q1	$22.8M	Buy	605,399 +10,945	+2%	+$484K	﹤0.01%	2299
2021 Q4	$36.9M	Buy	594,454 +279,640	+89%	+$21.2M	﹤0.01%	2025
2021 Q3	$26.9M	Buy	314,814 +8,863	+3%	+$556K	﹤0.01%	2264
2021 Q2	$18.9M	Buy	305,951 +31,941	+12%	+$1.63M	﹤0.01%	2552
2021 Q1	$13.4M	Buy	274,010 +20,740	+8%	+$1M	﹤0.01%	2603
2020 Q4	$7.89M	Buy	253,270 +3,539	+1%	+$86.7K	﹤0.01%	2754
2020 Q3	$5.21M	Sell	249,731 -1,032	-0.4%	-$17.7K	﹤0.01%	2757
2020 Q2	$3.27M	Buy	250,763 +6,295	+3%	+$68.4K	﹤0.01%	2977
2020 Q1	$2.21M	Buy	244,468 +5,559	+2%	+$52.7K	﹤0.01%	3022
2019 Q4	$2.45M	Buy	238,909 +7,244	+3%	+$82.1K	﹤0.01%	3176
2019 Q3	$3.35M	Buy	231,665 +62,105	+37%	+$961K	﹤0.01%	2988
2019 Q2	$1.77M	Buy	+169,560	New	+$2.29M	﹤0.01%	3289

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

State Street's OPRX Position: Q2 2026 in Review

State Street reduced its OptimizeRx (OPRX) stake by 83% in Q2 2026, selling an estimated $2.28M and leaving 80,602 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #3614.

State Street first reported a position in OPRX in Q2 2019 and has held it in 29 quarters since. The position peaked at $36.9M in Q4 2021. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

State Street held 80,602 shares of OptimizeRx worth $461K as of Q2 2026.
State Street sold 397,178 OptimizeRx shares in Q2 2026, an estimated $2.28M.
OptimizeRx made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3614 holding.
State Street first reported a position in OptimizeRx in Q2 2019 and has held it in 29 quarters since.
State Street's OptimizeRx position peaked at $36.9M in Q4 2021.
113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.